Zum Hauptinhalt springen

Gabapentinoide

03. Mai 2026 | Gabapentinoide

Association between gabapentinoid treatment, concurrent use with opioid or benzodiazepine and the risk of drug poisoning: A self-controlled case series study.

Association between gabapentinoid treatment, concurrent use with opioid or benzodiazepine and the risk of drug poisoning: A self-controlled case series study. Yuen ASC, Chen B, Chan AYL, Hayes JF, Osborn DPJ, Besag FMC, et al. (2026) P…

24. April 2026 | Gabapentinoide

Gabapentinoids and unexplained death in general practice: Case series and feasibility study arising from a critical incident.

Gabapentinoids and unexplained death in general practice: Case series and feasibility study arising from a critical incident. Gabriel A, Fahey T. Eur J Gen Pract. 2026 Dec;32(1):2645473. doi: 10.1080/13814788.2026.2645473. Epub 2026 Ma…

24. April 2026 | Gabapentinoide

Trends in pregabalin misuse and abuse: A 25-year bibliometric perspective.

Trends in pregabalin misuse and abuse: A 25-year bibliometric perspective. Aksun S, Oguz KF, Üge M, Cafer B. J Med Biochem. 2026 Jan 6;44(9):1902-1909. doi: 10.5937/jomb0-59752. PMID: 41799730; PMCID: PMC12967192. https://pmc.ncbi.nlm…

05. April 2026 | Gabapentinoide

Schweiz. Positionspapier der SSAM zum Abhängigkeitspotential von Pregabalin und den Implikationen für den klinischen Alltag

Schweiz. Positionspapier der SSAM zum Abhängigkeitspotential von Pregabalin und den Implikationen für den klinischen Alltag Ausgangssituation: Pregabalin ist ein von der Swissmedic für diverse somatische und psychiatrische Indikationen zugelassene…

25. März 2026 | Gabapentinoide

Second-Degree Atrioventricular Block Following Acute Pregabalin Intoxication: A Case Report.

Second-Degree Atrioventricular Block Following Acute Pregabalin Intoxication: A Case Report. Regaieg K, Chaouch S, Alila I, Kallel M, Pagis B. Cureus. 2026 Jan 7;18(1):e101010. doi: 10.7759/cureus.101010. PMID: 41658624; PMCID: PMC1288…

25. März 2026 | Gabapentinoide

Oral Side Effects of the Most Commonly Prescribed Drugs in Germany.

Oral Side Effects of the Most Commonly Prescribed Drugs in Germany. Halling F, Lutz R, Meisgeier A. Dent J (Basel). 2026 Feb 2;14(2):83. doi: 10.3390/dj14020083. PMID: 41744921; PMCID: PMC12939356. https://pmc.ncbi.nlm.nih.gov/article…

21. Februar 2026 | Gabapentinoide

Use of gabapentin with or without a prescription in substance use treatment settings: A national analysis of urine drug testing data, 2016-2023.

Use of gabapentin with or without a prescription in substance use treatment settings: A national analysis of urine drug testing data, 2016-2023. Ellis MS, Whitley P, Passik SD. Drug Alcohol Depend. 2026 Feb 1;279:113020. doi: 10.1016/j…

Weitere
akutelle Informationen
zu den Themengebieten